Advances in Immunotherapy for Melanoma: A Comprehensive Review.

about

Intratumor and Intertumor Heterogeneity in Melanoma.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Trial watch: DNA-based vaccines for oncological indications

P2860

Q46742817-1A84D218-311C-4E09-AF5E-AC7DD56F2E9B Q47135720-62E2DE7E-2E77-4A30-816C-A65052F6297C Q56893452-7B257E58-15BE-416B-AB7D-40CF67633501

P2860

Advances in Immunotherapy for Melanoma: A Comprehensive Review.

Item

http://www.wikidata.org/entity/Q38636521

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advances in Immunotherapy for Melanoma: A Comprehensive Review.

@en

type

Item

label

Advances in Immunotherapy for Melanoma: A Comprehensive Review.

@en

prefLabel

Advances in Immunotherapy for Melanoma: A Comprehensive Review.

@en

P1476

Advances in Immunotherapy for Melanoma: A Comprehensive Review

@en

P2093

Adriana López-Barcenas

http://www.w3.org/2001/XMLSchema#string

Ardiana Sinani

http://www.w3.org/2001/XMLSchema#string

Beatriz Sánchez-Blanco

http://www.w3.org/2001/XMLSchema#string

Brunilda Bardhi

http://www.w3.org/2001/XMLSchema#string

Elena Sánchez-Blanco

http://www.w3.org/2001/XMLSchema#string

Gabriella Fabbrocini

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cancer immunotherapy: the beginning of the end of cancer?

Cancer Microenvironment and Endoplasmic Reticulum Stress Response

Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer

Progression of cutaneous melanoma: implications for treatment

Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination

Monitoring of the Immune Dysfunction in Cancer Patients

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Long-term outcomes of helper peptide vaccination for metastatic melanoma.

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.

Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia.

P304

3264217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/3264217

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Miguel Carnero Gregorio

C Rodriguez-Cerdeira

Roberto Arenas Guzman

P5008

ScienceSource

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28848246

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

melanoma

P932

5564072

http://www.w3.org/2001/XMLSchema#string

Advances in Immunotherapy for Melanoma: A Comprehensive Review.

about

P2860

P2860

Advances in Immunotherapy for Melanoma: A Comprehensive Review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932